Screening for occult cancer: where are we in 2020?
The relationship between venous thromboembolism (VTE) and cancer has become an area of intense debate due to the importance and the potential benefits of the identification of occult cancer following the diagnosis of unprovoked VTE. At present, extended screening is not recommended in patients with...
Gespeichert in:
| Veröffentlicht in: | Thrombosis research 2020-07, Vol.191, p.S12-S16 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S16 |
|---|---|
| container_issue | |
| container_start_page | S12 |
| container_title | Thrombosis research |
| container_volume | 191 |
| creator | Marín-Romero, Samira Jara-Palomares, Luis |
| description | The relationship between venous thromboembolism (VTE) and cancer has become an area of intense debate due to the importance and the potential benefits of the identification of occult cancer following the diagnosis of unprovoked VTE. At present, extended screening is not recommended in patients with unprovoked VTE. However, if we were able to identify a group at greater risk of presenting cancer during follow-up, these patients would benefit from extended screening. The creation of a trans-organ screening model enables the unification of metrics of quality in the screening of cancer in different localizations. Likewise, it can incorporate cancer screening for other localizations or other specific situations of risk such as unprovoked VTE. This study summarizes the contribution of the Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) initiative aimed at improving the cancer screening process. Likewise, we have carried out an updated review of unprovoked VTE and occult cancer. Finally, we discuss the studies currently ongoing aimed at identifying the population at greatest risk of presenting cancer during follow-up. The identification of this population at high risk could help to determine the following steps to undertake in order to implement screening in this population. |
| doi_str_mv | 10.1016/S0049-3848(20)30390-X |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2429785459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S004938482030390X</els_id><sourcerecordid>2429785459</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-de1c8219b284ee5cb4cda836177958740b29510e5399a2c4cfa5d72985e6de233</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EouXxCaAsyyLgZ2yzqVDFS6rEoiB1ZznOBIzSpNgJFX9P-qBbFqPZnDtXcxC6IPiaYJLdzDDmOmWKqxHFVwwzjdP5ARoSJXVKuaSHaLhHBugkxk-MiSRaHKMBo5JlMtNDRGcuANS-fk_KJiSNc13VJs7WDsJtsvqAAIntZwWJrxOKKR6foaPSVhHOd_sUvT3cv06e0unL4_Pkbpo6lok2LYA4RYnOqeIAwuXcFVaxjEiphZIc51QLgkEwrS113JVWFJJqJSArgDJ2ikbbu8vQfHUQW7Pw0UFV2RqaLhrKqZZKcKF7VGxRF5oYA5RmGfzChh9DsFnrMhtdZu3CUGw2usy8z13uKrp8AcU-9eenB8ZbAPpHvz0EE52HXk7hA7jWFI3_p-IXxxl3Hw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2429785459</pqid></control><display><type>article</type><title>Screening for occult cancer: where are we in 2020?</title><source>Elsevier ScienceDirect Journals</source><creator>Marín-Romero, Samira ; Jara-Palomares, Luis</creator><creatorcontrib>Marín-Romero, Samira ; Jara-Palomares, Luis</creatorcontrib><description>The relationship between venous thromboembolism (VTE) and cancer has become an area of intense debate due to the importance and the potential benefits of the identification of occult cancer following the diagnosis of unprovoked VTE. At present, extended screening is not recommended in patients with unprovoked VTE. However, if we were able to identify a group at greater risk of presenting cancer during follow-up, these patients would benefit from extended screening. The creation of a trans-organ screening model enables the unification of metrics of quality in the screening of cancer in different localizations. Likewise, it can incorporate cancer screening for other localizations or other specific situations of risk such as unprovoked VTE. This study summarizes the contribution of the Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) initiative aimed at improving the cancer screening process. Likewise, we have carried out an updated review of unprovoked VTE and occult cancer. Finally, we discuss the studies currently ongoing aimed at identifying the population at greatest risk of presenting cancer during follow-up. The identification of this population at high risk could help to determine the following steps to undertake in order to implement screening in this population.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/S0049-3848(20)30390-X</identifier><identifier>PMID: 32736769</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Cancer ; Diagnostic screening programs ; Early detection of cancer ; Pulmonary embolism ; Risk factors ; Venous thromboembolism</subject><ispartof>Thrombosis research, 2020-07, Vol.191, p.S12-S16</ispartof><rights>2020 Elsevier Ltd</rights><rights>2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-de1c8219b284ee5cb4cda836177958740b29510e5399a2c4cfa5d72985e6de233</citedby><cites>FETCH-LOGICAL-c365t-de1c8219b284ee5cb4cda836177958740b29510e5399a2c4cfa5d72985e6de233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S004938482030390X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32736769$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marín-Romero, Samira</creatorcontrib><creatorcontrib>Jara-Palomares, Luis</creatorcontrib><title>Screening for occult cancer: where are we in 2020?</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>The relationship between venous thromboembolism (VTE) and cancer has become an area of intense debate due to the importance and the potential benefits of the identification of occult cancer following the diagnosis of unprovoked VTE. At present, extended screening is not recommended in patients with unprovoked VTE. However, if we were able to identify a group at greater risk of presenting cancer during follow-up, these patients would benefit from extended screening. The creation of a trans-organ screening model enables the unification of metrics of quality in the screening of cancer in different localizations. Likewise, it can incorporate cancer screening for other localizations or other specific situations of risk such as unprovoked VTE. This study summarizes the contribution of the Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) initiative aimed at improving the cancer screening process. Likewise, we have carried out an updated review of unprovoked VTE and occult cancer. Finally, we discuss the studies currently ongoing aimed at identifying the population at greatest risk of presenting cancer during follow-up. The identification of this population at high risk could help to determine the following steps to undertake in order to implement screening in this population.</description><subject>Cancer</subject><subject>Diagnostic screening programs</subject><subject>Early detection of cancer</subject><subject>Pulmonary embolism</subject><subject>Risk factors</subject><subject>Venous thromboembolism</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkMtOwzAQRS0EouXxCaAsyyLgZ2yzqVDFS6rEoiB1ZznOBIzSpNgJFX9P-qBbFqPZnDtXcxC6IPiaYJLdzDDmOmWKqxHFVwwzjdP5ARoSJXVKuaSHaLhHBugkxk-MiSRaHKMBo5JlMtNDRGcuANS-fk_KJiSNc13VJs7WDsJtsvqAAIntZwWJrxOKKR6foaPSVhHOd_sUvT3cv06e0unL4_Pkbpo6lok2LYA4RYnOqeIAwuXcFVaxjEiphZIc51QLgkEwrS113JVWFJJqJSArgDJ2ikbbu8vQfHUQW7Pw0UFV2RqaLhrKqZZKcKF7VGxRF5oYA5RmGfzChh9DsFnrMhtdZu3CUGw2usy8z13uKrp8AcU-9eenB8ZbAPpHvz0EE52HXk7hA7jWFI3_p-IXxxl3Hw</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Marín-Romero, Samira</creator><creator>Jara-Palomares, Luis</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202007</creationdate><title>Screening for occult cancer: where are we in 2020?</title><author>Marín-Romero, Samira ; Jara-Palomares, Luis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-de1c8219b284ee5cb4cda836177958740b29510e5399a2c4cfa5d72985e6de233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cancer</topic><topic>Diagnostic screening programs</topic><topic>Early detection of cancer</topic><topic>Pulmonary embolism</topic><topic>Risk factors</topic><topic>Venous thromboembolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marín-Romero, Samira</creatorcontrib><creatorcontrib>Jara-Palomares, Luis</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marín-Romero, Samira</au><au>Jara-Palomares, Luis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Screening for occult cancer: where are we in 2020?</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2020-07</date><risdate>2020</risdate><volume>191</volume><spage>S12</spage><epage>S16</epage><pages>S12-S16</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>The relationship between venous thromboembolism (VTE) and cancer has become an area of intense debate due to the importance and the potential benefits of the identification of occult cancer following the diagnosis of unprovoked VTE. At present, extended screening is not recommended in patients with unprovoked VTE. However, if we were able to identify a group at greater risk of presenting cancer during follow-up, these patients would benefit from extended screening. The creation of a trans-organ screening model enables the unification of metrics of quality in the screening of cancer in different localizations. Likewise, it can incorporate cancer screening for other localizations or other specific situations of risk such as unprovoked VTE. This study summarizes the contribution of the Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) initiative aimed at improving the cancer screening process. Likewise, we have carried out an updated review of unprovoked VTE and occult cancer. Finally, we discuss the studies currently ongoing aimed at identifying the population at greatest risk of presenting cancer during follow-up. The identification of this population at high risk could help to determine the following steps to undertake in order to implement screening in this population.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>32736769</pmid><doi>10.1016/S0049-3848(20)30390-X</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0049-3848 |
| ispartof | Thrombosis research, 2020-07, Vol.191, p.S12-S16 |
| issn | 0049-3848 1879-2472 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2429785459 |
| source | Elsevier ScienceDirect Journals |
| subjects | Cancer Diagnostic screening programs Early detection of cancer Pulmonary embolism Risk factors Venous thromboembolism |
| title | Screening for occult cancer: where are we in 2020? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T00%3A06%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Screening%20for%20occult%20cancer:%20where%20are%20we%20in%202020?&rft.jtitle=Thrombosis%20research&rft.au=Mar%C3%ADn-Romero,%20Samira&rft.date=2020-07&rft.volume=191&rft.spage=S12&rft.epage=S16&rft.pages=S12-S16&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/S0049-3848(20)30390-X&rft_dat=%3Cproquest_cross%3E2429785459%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2429785459&rft_id=info:pmid/32736769&rft_els_id=S004938482030390X&rfr_iscdi=true |